Login
Toggle sidebar

Lint: pembrolizumab-induced-sarcoid-like-reaction-1

pembrolizumab-induced-sarcoid-like-reaction-1
Headings Spacing
error

"See also "

Line 2:1 · Never put spaces at either end of headings.
Accepted Abbreviations
warning

"Pembrolizumab-induced sarcoid-like reaction (c.2019) is a phenomenon which has been associated with the use of the programmed cell death protein 1 (PD1) inhibitor pembrolizumab. It could be mistaken for metastatic disease in some situations."

Line 1:66 · Check the abbreviation form against the style guide: 'c.2019'.
Number Formatting
warning

"Pembrolizumab-induced sarcoid-like reaction (c.2019) is a phenomenon which has been associated with the use of the programmed cell death protein 1 (PD1) inhibitor pembrolizumab. It could be mistaken for metastatic disease in some situations."

Line 1:67 · Check the number format against the style guide: '.2019'.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"See also "

Line 2:1 · "See also " is not a recognised heading for this article type.
Links
0
0
0
0
0
0